PLoS ONE (Jan 2014)

Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in Meniere's disease.

  • Sonia Cabrera,
  • Elena Sanchez,
  • Teresa Requena,
  • Manuel Martinez-Bueno,
  • Jesus Benitez,
  • Nicolas Perez,
  • Gabriel Trinidad,
  • Andrés Soto-Varela,
  • Sofía Santos-Perez,
  • Eduardo Martin-Sanz,
  • Jesus Fraile,
  • Paz Perez,
  • Marta E Alarcon-Riquelme,
  • Angel Batuecas,
  • Juan M Espinosa-Sanchez,
  • Ismael Aran,
  • Jose A Lopez-Escamez

DOI
https://doi.org/10.1371/journal.pone.0112171
Journal volume & issue
Vol. 9, no. 11
p. e112171

Abstract

Read online

Meniere's disease is an episodic vestibular syndrome associated with sensorineural hearing loss (SNHL) and tinnitus. Patients with MD have an elevated prevalence of several autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis and psoriasis), which suggests a shared autoimmune background. Functional variants of several genes involved in the NF-κB pathway, such as REL, TNFAIP3, NFKB1 and TNIP1, have been associated with two or more immune-mediated diseases and allelic variations in the TLR10 gene may influence bilateral affectation and clinical course in MD. We have genotyped 716 cases of MD and 1628 controls by using the ImmunoChip, a high-density genotyping array containing 186 autoimmune loci, to explore the association of immune system related-loci with sporadic MD. Although no single nucleotide polymorphism (SNP) reached a genome-wide significant association (p40 dB HL) (log-rank test, corrected p values were p = 0.009 for rs3774937 and p = 0.003 for rs4648011, respectively). No variants influenced hearing in bilateral MD. Our data support that the allelic variants rs3774937 and rs4648011 can modify hearing outcome in patients with MD and unilateral SNHL.